Cytos Biotechnology AG

Quick facts

Phase 2 pipeline

• CYT002-NicQb
• CYT003-QbG10 · Autoimmune diseases
  CYT003-QbG10 is a therapeutic vaccine designed to treat autoimmune diseases by modulating the immune response.
• CYT004-MelQbG10
• CYT004-MelQbG10 intra nodal injection · Oncology
  CYT004-MelQbG10 is a therapeutic vaccine designed to stimulate an immune response against melanoma.
• CYT006-AngQb

Phase 1 pipeline

• CYT005-AllQbG10
• CYT013-IL1bQb

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Cytos Biotechnology AG portfolio CI brief
• Cytos Biotechnology AG pipeline updates RSS